NEW YORK, NY, October 25 – Biotech Policy Group, an industry leading healthcare regulatory policy and government relations consulting firm will be featured at the Medidata NEXT – The Vanguard Healthcare Forum in New York on October 24th and 25th, 2018.
Medidata NEXT – The Vanguard Healthcare Forum connects professionals in the Life Sciences to learn from and be inspired by an array of industry thought leaders. Medidata NEXT – The Vanguard Healthcare Forum stays on the cutting edge of clinical development as the industry undergoes exciting changes in the future.
Anne Marie Finley, President of Biotech Policy Group, will be featured discussing the Patient Centric Value Model. Medidata NEXT – The Vanguard Healthcare Forum also features former Second Lady, Dr. Jill Biden, who will be speaking on the Biden Cancer Initiative.
“Medidata NEXT – The Vanguard Healthcare Forum is an impressive gathering of Life Sciences professionals and I’m honored to be discussing the Patient Centric Value Model,” said Anne Marie Finley, president of Biotech Policy Group.
Medidata NEXT – The Vanguard Healthcare Forum is a two-day event being held at Spring Studios in New York on October 24th and 25th, 2018. Biotech Policy Group will be presenting on a panel in an early afternoon session at 1:30 pm eastern.
Biotech Policy Group specializes in developing regulatory and public policy solutions for pharmaceutical, biologic, diagnostic, medical device and food clients. Biotech Policy Group has extensive expertise in the development of products for rare diseases and unmet medical needs. Biotech Policy Group was founded in 2001 and has offices in Milwaukee, WI.
Biotech Policy Group President Anne Marie Finley was named a Top 50 Global Thought Leader in Orphan Drugs and Rare Diseases by the World Orphan Drug Congress in 2014, after a 20 year career in orphan drug development in senior level positions at the US Food and Drug Administration, US Department of Health and Human Services, Celgene, GE Healthcare, Amersham and as a consultant to many biotech companies, academic medical centers and patient organizations.
More information on Biotech Policy Group can be found at BiotechPolicyGroup.com.
Tim Vertz | email@example.com | 414.379.1677